Investors

Copyright West LLC. Minimum 15 minutes delayed.

News Release

<< Back
Apr 25, 2013

OvaScience to Participate in Panel Featuring Innovative Companies at Greater Boston Chamber of Commerce Women’s Network Breakfast

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 25, 2013-- OvaScienceSM, (OTC: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will be a featured speaker at the Greater Boston Chamber of Commerce Women’s Network Breakfast being held today at the Ritz-Carlton in Boston.

Dr. Dipp will participate in the panel “Women Leading & Growing Innovative Companies,” which is comprised of women from innovative companies in the Greater Boston business community. Other panelists include Diane Hessan, President and Chief Executive Officer of Communispace Corporation; Jules Pieri, Founder and Chief Executive Officer of Daily Grommet; and session moderator Patricia J. Guinan, Associate Professor of Information Systems of Babson College.

This week, OvaScience is also proud to support National Infertility Awareness Week®, an issue that affects a growing number of women, couples and families worldwide.

About OvaScience

OvaScience (OTC: OVSC) is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility. The Company’s patented technology is based on the discovery of egg precursor cells (EggPCSM), which are found in the ovaries. By applying proprietary technology to identify and purify EggPCs, AUGMENTSM aims to improve egg quality and increase the success of in vitro fertilization (IVF). OvaScience’s team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine. For more information, please visit www.ovascience.com.

Source: OvaScience

OvaScience, Inc.
Theresa McNeely, 617-299-7356
Head of Corporate Communications
tmcneely@ovascience.com